NCT04364776 2023-09-28Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.Fondazione IRCCS Policlinico San Matteo di PaviaUnknown100 enrolled
NCT04107168 2023-02-16Microbiome Immunotherapy Toxicity and Response EvaluationCambridge University Hospitals NHS Foundation TrustUnknown1,800 enrolled